A short-cycle ADFR regimen using parathyroid peptide hPTH 1–34 in idiopathic osteoporosis

Eitemau Tebyg

• Calcium-47 kinetic measurements of bone turnover compared to bone histomorphometry in osteoporosis: the influence of human parathyroid fragment (hPTH 1-34) therapy.
  gan: Reeve, J, et al.
  Cyhoeddwyd: (1981)
• Further observations on the treatment of involutional osteoporosis with hPTH 1–34; The effects of added estrogens
  gan: Reeve, J, et al.
  Cyhoeddwyd: (1986)
• hPTH 1-34 treatment of osteoporosis with added hormone replacement therapy: biochemical, kinetic and histological responses.
  gan: Reeve, J, et al.
  Cyhoeddwyd: (1991)
• The relationship between changes in femoral bone density and calcium balance in patients with involutional osteoporosis treated with human parathyroid hormone fragment (hPTH 1–34)
  gan: Hesp, R, et al.
  Cyhoeddwyd: (1981)
• Treatment of osteoporosis with parathyroid peptide (hPTH 1-34) and oestrogen: increase in volumetric density of iliac cancellous bone may depend on reduced trabecular spacing as well as increased thickness of packets of newly formed bone.
  gan: Bradbeer, J, et al.
  Cyhoeddwyd: (1992)